摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-(二乙氨基)乙基]硬脂酰胺 | 16889-14-8

中文名称
N-[2-(二乙氨基)乙基]硬脂酰胺
中文别名
N-[2-(二乙基氨基)乙基]十八酰胺;硬脂酰胺乙基二乙胺
英文名称
diethylaminoethyl stearamide
英文别名
Stearinsaeure-<2-diaethylamino-aethylamid>;N-(2-diethylamino-ethyl)-stearamide;N-(2-Diaethylamino-aethyl)-stearamid;stearamidoethyl diethylamine;N-[2-(diethylamino)ethyl]octadecanamide
N-[2-(二乙氨基)乙基]硬脂酰胺化学式
CAS
16889-14-8
化学式
C24H50N2O
mdl
MFCD00026659
分子量
382.674
InChiKey
KKBOOQDFOWZSDC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    61-62 °C
  • 沸点:
    506.7±33.0 °C(Predicted)
  • 密度:
    0.873±0.06 g/cm3(Predicted)
  • LogP:
    8.295 (est)

计算性质

  • 辛醇/水分配系数(LogP):
    8.7
  • 重原子数:
    27
  • 可旋转键数:
    21
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.958
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2924199090

SDS

SDS:e998f252f5fae0ac202a563638f720c2
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-[2-(二乙氨基)乙基]硬脂酰胺 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃乙醚 、 Petroleum ether 为溶剂, 反应 5.5h, 生成 1-[2-(Diethylamino)ethyl]-1-octadecyl-3-phenylurea
    参考文献:
    名称:
    Detert; Seifert; Schunack, Pharmazie, 1996, vol. 51, # 2, p. 67 - 72
    摘要:
    DOI:
  • 作为产物:
    描述:
    N,N-二乙基乙二胺十八烷酰氯乙醚 为溶剂, 以94%的产率得到N-[2-(二乙氨基)乙基]硬脂酰胺
    参考文献:
    名称:
    Detert; Seifert; Schunack, Pharmazie, 1996, vol. 51, # 2, p. 67 - 72
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] PHENOTHIAZINE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE PHÉNOTHIAZINE ET LEURS UTILISATIONS
    申请人:CAMP4 THERAPEUTICS CORP
    公开号:WO2019195789A1
    公开(公告)日:2019-10-10
    The present invention provides phenothiazine compounds, processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment of various diseases or conditions, for example ribosomal disorders and ribosomopathies, e.g. Diamond Blackfan anemia (DBA).
    本发明提供了吩噻嗪化合物,其制备方法,包含该化合物的药物组合物,以及在治疗各种疾病或症状中使用该化合物或组合物,例如核糖体紊乱和核糖体病,例如钻石-布莱克范贫血(DBA)。
  • DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF
    申请人:RNS CO.,LTD.
    公开号:US20150283051A1
    公开(公告)日:2015-10-08
    Provided is a skin whitening composition with excellent whitening effects, specifically, a derivative or a polyhydroxy cyclic compound represented by Formula I or a pharmacologically acceptable salt thereof, comprising; wherein is derived from an aromatic cyclic compound, C n , C n+1 and C n+2 are three neighboring carbon atoms present in the aromatic cyclic compound, wherein n is a positive integer, R 1 and R 2 are each a saturated or unsaturated straight or branched alkyl or acyl group having 3 to 12 carbon atoms, and R 3 , R 4 , R 5 and R 6 are each independently at least one substituent selected from hydrogen, alkyl, alkoxy, acyloxy, acyloxymethyl, oxo, hydroxy, vinyl, nitrile, carboxaldehyde, carbonitrile and aldehyde.
    提供一个具有优异美白效果的皮肤美白组合物,具体为公式I所表示的衍生物或多元醇环化合物或其药理上可接受的盐,其中 所述的芳香族环化合物,C n ,C n+1 和C n+2 是存在于芳香族环化合物中的三个相邻的碳原子,其中n是正整数,R 1 和R 2 分别是具有3至12个碳原子的饱和或不饱和直链或支链烷基或酰基,而R 3 ,R 4 ,R 5 和R 6 各自独立地选自氢、烷基、烷氧基、酰氧基、酰氧甲基、氧代、羟基、乙烯基、腈、羧醛、碳腈和醛中至少一个取代基。
  • BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
    申请人:SENOMYX, INC.
    公开号:US20160376263A1
    公开(公告)日:2016-12-29
    The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.
    本发明涵盖已知用于改变苦味感知的化合物和组合物,以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种:冷却剂;无活性药物成分;活性药用成分;食品添加剂或食品;调味剂或调味增强剂;食品或饮料产品;苦味化合物;甜味剂;苦味剂;酸味调味剂;咸味调味剂;鲜味调味剂;植物或动物产品;已知用于宠物护理产品中的化合物;已知用于个人护理产品中的化合物;已知用于家用产品中的化合物;制药制剂;局部制剂;大麻衍生或与大麻相关的产品;已知用于口腔护理产品中的化合物;饮料;香味、香水或除臭剂;已知用于消费品中的化合物;硅化合物;磨料;表面活性剂;发热剂;吸烟物品;脂肪、油脂或乳化剂;和/或益生菌或补充剂。
  • SKIN EXTERNAL PREPARATIONS AND COSMETICS
    申请人:Aoki Hirobumi
    公开号:US20100280111A1
    公开(公告)日:2010-11-04
    An object of the present invention is to provide skin external preparations and cosmetics which contain a branched acyl carnitine and have excellent formulation stability. A skin external preparation of the present invention includes a carnitine derivative represented by the following Formula (1) and/or a carnitine derivative salt represented by the following Formula (2), and an amphoteric surfactant. In Formula (1), R 1 and R 2 are each independently a C1-18 optionally branched, saturated or unsaturated aliphatic hydrocarbon group. In Formula (2), R 1 and R 2 are the same as in Formula (1), X − is a specific anion and Y + is a specific cation.
    本发明的一个目的是提供含有支链酰基肉碱并具有优异配方稳定性的皮肤外用制剂和化妆品。本发明的皮肤外用制剂包括以下式(1)所表示的肉碱衍生物和/或以下式(2)所表示的肉碱衍生物盐,以及一种两性表面活性剂。在式(1)中,R1和R2分别独立地是C1-18的可选支链、饱和或不饱和脂肪烃基。在式(2)中,R1和R2与式(1)中相同,X−是特定的阴离子,Y+是特定的阳离子。
  • Particles with improved solubilization capacity
    申请人:——
    公开号:US20030022242A1
    公开(公告)日:2003-01-30
    A particle is disclosed that comprises a first volume of hydrophobe-rich material with tunable dissolution and solubilization characteristics and a distinct second volume of nanostructured nonlamellar liquid crystalline material, said second volume containing said first domain and being capable of being in equilibrium with said first volume. Preferably, the nanostructured nonlamellar liquid crystalline material is capable of being in equilibrium with a polar solvent or a water-immiscible solvent or both.
    揭示了一种颗粒,包括具有可调溶解和溶解特性的第一体积的疏水基质材料和独特的第二体积的纳米结构非层状液晶材料,所述第二体积包含所述第一领域,并能够与所述第一体积处于平衡状态。优选,所述纳米结构非层状液晶材料能够与极性溶剂或水不相溶溶剂或两者同时处于平衡状态。
查看更多